India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Breast cancer causes and treatment Recently, the problem of breast cancer in women is increasing. The exact cause of breast cancer cannot be said. 5 to 10 percent of these are also hereditary. The Nepal Health Research Council conducted a study on breast cancer in seven districts of Nepal, out of which the number of women with breast cancer was very high in five districts. Various studies have shown that women between the ages of 50 and 60 are more prone to breast cancer than others. In Nepal, breast cancer is more common among women in the age group of 40 to 50 years. Symptoms The main symptom of breast cancer is swelling in the breast. Such a sore throat is painless and grows. There are problems such as burying of nipples, discoloration, thickening of the skin, pus or bleeding from nipples, and non-healing of wounds. identification Symptoms of breast cancer can appear very late. Therefore, if you want to detect breast cancer in time, you should not wait for the symptoms. Women o...